Abstract Details
|
Lawrence Hewitt
(Lundbeck)
PRESENTER |
Lawrence Hewitt has received personal compensation for serving as an employee of Lundbeck. |
| Adam Ziemann, MD, PhD (Eli Lilly) | Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie. |
| No disclosure on file | |
| No disclosure on file | |
| Steven Vernino, MD, PhD, FAAN (UT Southwestern Medical Center) | Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities. |